| Schedule of results by segment |
| | | | | | | | | | | | | | | | | | | | | | | | Three months ended November 27, 2025 | CMBU | CDBU | MCBU | AEBU | All Other | Unallocated | Total | | | | | | | | | | Revenue | $ | 5,284 | | $ | 2,379 | | $ | 4,255 | | $ | 1,720 | | $ | 5 | | $ | — | | $ | 13,643 | | | Cost of goods sold | 1,817 | | 1,157 | | 1,970 | | 942 | | 4 | | 107 | | 5,997 | | | Gross margin | 3,467 | | 1,222 | | 2,285 | | 778 | | 1 | | (107) | | 7,646 | | | | | | | | | | | Research and development | 500 | | 291 | | 176 | | 97 | | — | | 107 | | 1,171 | | | Selling, general, and administrative | 83 | | 41 | | 92 | | 54 | | — | | 67 | | 337 | | | Other operating (income) expense, net | — | | — | | — | | — | | — | | 2 | | 2 | | Operating income | $ | 2,884 | | $ | 890 | | $ | 2,017 | | $ | 627 | | $ | 1 | | $ | (283) | | $ | 6,136 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three months ended November 28, 2024 | CMBU | CDBU | MCBU | AEBU | All Other | Unallocated | Total | | | | | | | | | | Revenue | $ | 2,648 | | $ | 2,292 | | $ | 2,608 | | $ | 1,158 | | $ | 3 | | $ | — | | $ | 8,709 | | | Cost of goods sold | 1,293 | | 1,149 | | 1,899 | | 922 | | 5 | | 93 | | 5,361 | | | Gross margin | 1,355 | | 1,143 | | 709 | | 236 | | (2) | | (93) | | 3,348 | | | | | | | | | | | Research and development | 252 | | 218 | | 234 | | 108 | | (1) | | 77 | | 888 | | | Selling, general, and administrative | 37 | | 54 | | 96 | | 50 | | 1 | | 50 | | 288 | | | Other operating (income) expense, net | — | | — | | — | | — | | (2) | | — | | (2) | | Operating income | $ | 1,066 | | $ | 871 | | $ | 379 | | $ | 78 | | $ | — | | $ | (220) | | $ | 2,174 | |
|
| Schedule of unallocated amounts [reconciliation of operating profit (loss) from segments to consolidated] |
The table below presents the unallocated amounts: | | | | | | | | | | Three months ended | November 27,
2025 | November 28,
2024 | | | | | Unallocated | | | Cost of goods sold: | | | | Stock-based compensation | $ | 107 | | $ | 90 | | Other | — | | 3 | | | 107 | | 93 | | Research and development: | | | | Stock-based compensation | 106 | | 77 | | Other | 1 | | — | | | 107 | | 77 | | Selling, general, and administrative: | | | | Stock-based compensation | 67 | | 50 | | | | Other operating (income) expense, net: | | | | | | | Other | 2 | | — | | | 2 | | — | | | | | Total unallocated amounts | $ | 283 | | $ | 220 | |
|